BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2455 related articles for article (PubMed ID: 9065053)

  • 21. [Treatment of ANCA associated systemic necrotizing vasculitides].
    Guillevin L
    Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microscopic polyangiitis].
    Venetz JP; Rossert J
    Ann Med Interne (Paris); 2000 May; 151(3):193-8. PubMed ID: 10896971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathology of ANCA-associated vasculitis.
    Csernok E; Müller A; Gross WL
    Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ANCA (antineutrophil cytoplasmic antibodies). Contribution of ANCA to the understanding of pathogenic mechanisms of systemic vasculitis].
    De Bandt M
    Ann Med Interne (Paris); 1997; 148(8):542-62. PubMed ID: 9538401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
    Tervaert JW; Stegeman CA; Brouwer E; Mulder AH; Limburg PC; Kallenberg CG
    Neth J Med; 1994 Dec; 45(6):262-72. PubMed ID: 7838242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Causes and mechanisms of vasculitides].
    Lesavre P; Noël LH
    Rev Prat; 2000 Feb; 50(3):255-60. PubMed ID: 11923948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Crescentic glomerulonephritis].
    Esnault VL; Moreau A; Testa A; Besnier D
    Nephrol Ther; 2006 Dec; 2(7):446-60. PubMed ID: 17185236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
    Reinhold-Keller E; Tatsis E; Gross WL
    Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological atlas of renal diseases: ANCA-associated vasculitis (first part).
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(2):113-6. PubMed ID: 15931638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kidney involvement in systemic necrotizing vasculitis].
    Chauveau D; Guittard J; Mehrenberger M; Pourrat J
    Rev Prat; 2008 Mar; 58(5):499-506. PubMed ID: 18524106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
    Sørensen SF; Slot O; Tvede N; Petersen J
    Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
    Mahr AD
    APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
    Savige JA; Chang L; Wilson D; Buchanan RR
    Rheumatol Int; 1996; 16(3):109-14. PubMed ID: 8893375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
    Csernok E; Gross WL
    Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurological involvement in Wegener's granulomatosis].
    Asakura K; Muto T
    Brain Nerve; 2013 Nov; 65(11):1311-7. PubMed ID: 24200609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease].
    Wieczorek-Surdacka E; Kaczmarczyk I; Jasik P; Przepiórkowska-Hoyer B; Sułowicz W
    Przegl Lek; 2011; 68(2):123-5. PubMed ID: 21751523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 123.